OA07586A - Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation. - Google Patents

Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation.

Info

Publication number
OA07586A
OA07586A OA58156A OA58156A OA07586A OA 07586 A OA07586 A OA 07586A OA 58156 A OA58156 A OA 58156A OA 58156 A OA58156 A OA 58156A OA 07586 A OA07586 A OA 07586A
Authority
OA
OAPI
Prior art keywords
quinolizine
benzo
dihydro
oxo
dimethyl
Prior art date
Application number
OA58156A
Other languages
English (en)
French (fr)
Inventor
Richard M Stern
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of OA07586A publication Critical patent/OA07586A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
OA58156A 1982-11-12 1983-11-10 Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation. OA07586A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/441,245 US4472405A (en) 1982-11-12 1982-11-12 Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives

Publications (1)

Publication Number Publication Date
OA07586A true OA07586A (fr) 1985-03-31

Family

ID=23752110

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58156A OA07586A (fr) 1982-11-12 1983-11-10 Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation.

Country Status (22)

Country Link
US (1) US4472405A (xx)
EP (1) EP0109284B1 (xx)
JP (1) JPH0826017B2 (xx)
KR (1) KR890000864B1 (xx)
AT (1) ATE39926T1 (xx)
AU (1) AU568319B2 (xx)
CA (2) CA1254568A (xx)
CS (1) CS390391A3 (xx)
DE (1) DE3378912D1 (xx)
EG (1) EG16492A (xx)
ES (1) ES8504727A1 (xx)
FI (1) FI73213C (xx)
GR (1) GR79402B (xx)
IE (1) IE56232B1 (xx)
IL (1) IL70198A (xx)
IN (1) IN161391B (xx)
MX (1) MX7314E (xx)
NO (1) NO160782C (xx)
NZ (1) NZ206233A (xx)
OA (1) OA07586A (xx)
PT (1) PT77649B (xx)
ZA (1) ZA838436B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519926A1 (de) * 1985-06-04 1986-12-04 Bayer Ag Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel
CA1302413C (en) * 1986-01-22 1992-06-02 Bruce E. Williams Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo- 1h,5h-benzo[ij]quinolizine-2-carboxylic acid
US4898945A (en) * 1986-01-22 1990-02-06 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid
GB9827865D0 (en) * 1998-12-18 1999-02-10 Woodcock Fiona Medicament
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
AU2011315555B2 (en) 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
US10543170B2 (en) 2012-12-19 2020-01-28 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
CN114727622A (zh) * 2019-09-06 2022-07-08 礼蓝美国公司 适口颗粒状兽用药组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
ZA728444B (en) * 1971-12-30 1973-10-31 Riker Laboratories Inc Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS5655388A (en) 1979-10-11 1981-05-15 Otsuka Pharmaceut Co Ltd Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation
US4301289A (en) * 1980-02-19 1981-11-17 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid
JPS59155381A (ja) * 1983-02-22 1984-09-04 Kyorin Pharmaceut Co Ltd ベンゾキノリジンカルボン酸誘導体及びその製造法

Also Published As

Publication number Publication date
ATE39926T1 (de) 1989-01-15
EP0109284B1 (en) 1989-01-11
FI834147A (fi) 1984-05-13
IE56232B1 (en) 1991-05-22
IL70198A0 (en) 1984-02-29
KR840006659A (ko) 1984-12-01
JPH0826017B2 (ja) 1996-03-13
JPS59112969A (ja) 1984-06-29
US4472405A (en) 1984-09-18
PT77649B (en) 1986-03-19
CA1280755C (en) 1991-02-26
NO834093L (no) 1984-05-14
IN161391B (xx) 1987-11-28
EG16492A (en) 1994-11-30
FI73213B (fi) 1987-05-29
NO160782C (no) 1989-05-31
PT77649A (en) 1983-12-01
CS390391A3 (en) 1992-09-16
MX7314E (es) 1988-05-11
CA1254568A (en) 1989-05-23
FI73213C (fi) 1987-09-10
DE3378912D1 (de) 1989-02-16
IL70198A (en) 1988-11-15
ZA838436B (en) 1985-06-26
NZ206233A (en) 1986-10-08
IE832639L (en) 1984-05-12
FI834147A0 (fi) 1983-11-11
KR890000864B1 (ko) 1989-04-11
EP0109284A1 (en) 1984-05-23
ES527163A0 (es) 1985-05-01
ES8504727A1 (es) 1985-05-01
AU2118183A (en) 1984-05-17
NO160782B (no) 1989-02-20
GR79402B (xx) 1984-10-22
AU568319B2 (en) 1987-12-24

Similar Documents

Publication Publication Date Title
OA07586A (fr) Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation.
IE782070L (en) Azabicyclo (3.2.0) hept-2-ene carboxylic acid derivatives
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
FR2392964A1 (fr) Nouveaux derives de cyclopropane, leur procede de preparation et leur application comme insecticides
BE865124A (fr) Procede de preparation d'esters d'acides butane-dicarboxyliques
SE8904104D0 (sv) Stereospecifikt foerfarande foer framstaellning av furo/3,4-c/pyridinenantiomerer, de saa erhaallna foereningarna och terapeutiska kompositioner daerav
ES8106516A1 (es) Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos
BE864481A (fr) Esters m-phenoxybenzyliques d'acides (difluoro-2,2 benzodioxole-1,3)-5- alpha-alkylacetiques utiles comme insecticides et acaricides et procede de leur preparation
FR2427339A1 (fr) Nouveaux derives optiquement actifs d'oxazaphosphorine et leur procede de preparation
SE8005663L (sv) Forfarande for framstellning av en farmaceutiskt aktiv komposition
FR2396001A1 (fr) Derives a-acetyleniques et a-vinyliques d'amino-acides utiles comme medicaments et leur procede de preparation
OA06792A (fr) Procédé de préparation de dérivés esters d'acides cyclopropane-carboxylique.
BE880332A (fr) Procede de preparation de derives esters d'acide apovincaminique
SE8301687D0 (sv) 8-cyano-6,7-dihydro-5-metyl-1-oxo-1h-,5h-benso(ij)kinolizin-2-karboxylsyror och forfarande for framstellning derav
OA06793A (fr) Procédé de préparation de dérivés esters d'acides cyclopropane-carboxyliques.
ES2031833T3 (es) Procedimiento para la obtencion de nuevos arilmetoxitiofenoderivados nitrogenados.
BE864113A (fr) Procede de preparation d'esters d'acides diphenylalcanoiques
DK550183A (da) 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo/ij/-quinolizin-2-carboxylsyre, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved udoevelse af fremgangsmaaden
DE3461464D1 (en) Derivatives of d-2-(6-methoxy-2-naphthyl)-propionic acid having therapeutical activity, process for their preparation and pharmaceutical compositions containing them
FR2373549A1 (fr) Procede de transformation de 3-methylenecephalosporines en 3-heterothiomethylcephalosporines
GB2120250A (en) Enantiomers of 2,3,3a,4,5,6- hexahydro-1H-indolo(3,2,1- de)-[1,5-naphthyridine]
FI892587A (fi) Foerfarande foer framstaellning av gangliosidderivat.
BE863842A (fr) Procede de preparation de nouveaux derives d'acide indolyglyoxylique utiles comme medicaments
FR2531434B1 (fr) Procede de preparation d'esters boriques d'esters d'acides gras de glycerol
FR2532314B1 (fr) Nouveau procede de preparation de derives de l'acide 3-quinoleine carboxylique, nouveaux derives halogenes de l'acide 3-quinoleine carboxylique, leur application comme medicaments, les compositions pharmaceutiques les renfermant et les intermediaires nouveaux obtenus